SELLAS Life Sciences Grou...

NASDAQ: SLS · Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.63
0.62%
After-hours: Aug 15, 2025, 06:28 PM EDT

SELLAS Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 1M 7.6M
Cost of Revenue
n/a n/a 100K 200K
Gross Profit
n/a n/a 900K 7.4M
Operating Income
-31.51M -37.87M -41.95M -25.29M
Interest Income
632K 525K 317K 6K
Pretax Income
-30.88M -37.34M -41.3M -20.94M
Net Income
-30.88M -37.34M -41.3M -20.7M
Selling & General & Admin
12.42M 13.86M 12.58M 11.32M
Research & Development
19.1M 24.01M 30.27M 21.37M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
31.51M 37.87M 42.85M 32.69M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
31.51M 37.87M 42.95M 32.89M
Income Tax Expense
n/a n/a n/a -237K
Shares Outstanding (Basic)
612.02M 249.99M 19.4M 15.48M
Shares Outstanding (Diluted)
612.02M 249.99M 19.4M 15.48M
EPS (Basic)
-0.05 -0.15 -2.13 -1.34
EPS (Diluted)
-0.05 -0.15 -2.13 -1.34
EBITDA
-30.88M 529K -31.95M -19.59M
EBIT
-30.88M -37.34M -31.95M -19.59M
Depreciation & Amortization
31.51M 37.87M 457K 1.27M